Iijima, K. et al. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384, 1273–1281 (2014).
Article CAS PubMed Google Scholar
Watts, A. J. B. et al. Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology. J. Am. Soc. Nephrol. 33, 238–252 (2022).
Article CAS PubMed PubMed Central Google Scholar
Takeuchi, K. et al. New anti-nephrin antibody mediated podocyte injury model using a C57BL/6 mouse strain. Nephron 138, 71–87 (2018).
Article CAS PubMed Google Scholar
Hengel, F. E. et al. Autoantibodies targeting nephrin in podocytopathies. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2314471 (2024).
Zhang, Y. M. et al. Clinical significance of IgM and C3 glomerular deposition in primary focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 11, 1582–1589 (2016).
Article CAS PubMed PubMed Central Google Scholar
Pedchenko, V. et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N. Engl. J. Med. 363, 343–354 (2010).
Article CAS PubMed PubMed Central Google Scholar
Uhlin, F. et al. Endopeptidase cleavage of anti-glomerular basement membrane antibodies in vivo in severe kidney disease: an open-label phase 2a study. J. Am. Soc. Nephrol. 33, 829–838 (2022).
Article CAS PubMed PubMed Central Google Scholar
Beck, L. H. Jr et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 361, 11–21 (2009).
Article CAS PubMed PubMed Central Google Scholar
Fervenza, F. C. et al. Rituximab or cyclosporine in the treatment of membranous nephropathy. N. Engl. J. Med. 381, 36–46 (2019).
Article CAS PubMed Google Scholar
Haddad, G. et al. Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy. J. Clin. Invest. 131, e140453 (2021).
Comments (0)